State

Northern Mariana Islands product recalls

73,827 recalls have nationwide distribution and so reach Northern Mariana Islands. 23 additional recalls listed Northern Mariana Islands specifically in their distribution scope.

What the numbers show

Total: 23
Critical: 0
Severe: 18
Most recent: 2026-09-23

Of the 23 recalls naming Northern Mariana Islands we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 18 (78%) are Severe.

Which agencies issued them

These figures cover only the 23 recalls whose distribution notice names Northern Mariana Islands specifically. The 73,827 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

54351–54375 of 73850

HighFDA (Drugs)·D-848-2015·2015-04-29
Attix Pharmaceuticals Recalls Polidocanol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Polidocanol (Industrial Grade) active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Polidocanol (Industrial Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-835-2015·2015-04-29
Attix Pharmaceuticals Recalls Penciclovir Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling penciclovir active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Penciclovir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-784-2015·2015-04-29
Attix Pharmaceuticals Recalls Methocarbamol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling methocarbamol active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Methocarbamol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-782-2015·2015-04-29
Attix Pharmaceuticals Recalls Methimazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling methimazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging. The product was distributed nationwide to compounding pharmacies and research organizations.
Product
Methimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-558-2015·2015-04-29
Attix Pharmaceuticals Recalls Cantharidin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of cantharidin active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Product
Cantharidin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-741-2015·2015-04-29
Attix Pharmaceuticals Recalls Ketoconazole API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Ketoconazole active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Ketoconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-673-2015·2015-04-29
Attix Pharmaceuticals Recalls Felbamate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Felbamate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Felbamate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-524-2015·2015-04-29
Attix Pharmaceuticals Recalls Artemether Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Artemether active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Artemether active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1485-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 102 units of the Crosscheck Plating System because specific dimensions are out of specification, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, NEUTRAL, Right, REF CCP-LPX0R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-751-2015·2015-04-29
Attix Pharmaceuticals Recalls Letrazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Letrazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Letrazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1490-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 167 units of the Crosscheck Plating System because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, MTP NX Plate, Left, Recon, REF CCP-MPN2L. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-863-2015·2015-04-29
Attix Pharmaceuticals Recalls Procainamide HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Procainamide HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Procainamide HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-503-2015·2015-04-29
Adenosine API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Adenosine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Adenosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-732-2015·2015-04-29
Attix Pharmaceuticals Recalls Indocyanine Green Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Indocyanine Green active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Indocyanine Green active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1497-2015·2015-04-29
Wright Medical Crosscheck Plating System Recalled for Dimensional Defects
Wright Medical Technology is recalling 138 units of the Crosscheck Plating System because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, Utility Plate, 5-Hole, REF CCP-UTN5. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-935-2015·2015-04-29
Tolvaptan API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Tolvaptan active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-839-2015·2015-04-29
Attix Pharmaceuticals Recalls Phenolphthalein Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Phenolphthalein active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Phenolphthalein active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-786-2015·2015-04-29
Attix Pharmaceuticals Recalls Methotrexate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Methotrexate USP active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Methotrexate USP active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-860-2015·2015-04-29
Attix Pharmaceuticals Recalls Pregelatinized Starch Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Pregelatinized Starch pharmaceutical ingredients due to potential penicillin cross-contamination from inadequate facility separation.
Product
Pregelatinized Starch pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-650-2015·2015-04-29
Attix Pharmaceuticals Recalls Epinephrine Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling epinephrine active pharmaceutical ingredient distributed to compounding pharmacies and research organizations due to potential penicillin cross-contamination.
Product
Epinephrine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1488-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects
Wright Medical Technology is recalling 148 units of the Crosscheck Plating system because specific dimensions are out of specification, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, 2mm Step, Left, REF CCP-LPX2L. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-570-2015·2015-04-29
Attix Pharmaceuticals Recalls Celecoxib API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Celecoxib active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-660-2015·2015-04-29
Attix Pharmaceuticals Recalls Ethambutol HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Ethambutol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Ethambutol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1515-2015·2015-04-29
Abbott OptiMedica Catalys Precision Laser System Recalled for Corneal Scoring Risk
Abbott Medical Optics is recalling 202 OptiMedica Catalys Precision Laser Systems because loss of suction during cataract surgery may cause corneal scoring.
Product
OptiMedica Catalys Precision Laser System; Model No(s). Catalys-U (US), and Catalys-I (Outside US). Product Usage: Indicated for use in patients undergoing cataract surgery for removal of crystalline lens.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1470-2015·2015-04-29
Churchill Medical Systems Recalls 4-inch Microbore Trifurcated Extension Sets
Churchill Medical Systems is recalling 2,200 units of 4-inch Microbore Trifurcated Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and female luer.
Product
4" Microbore Trifurcated Ext set, Product Code: BN-308 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide